Summary
Boston Scientific Corporation (BSX) filed an 8-K on January 17, 2006, to announce a significant development in its pursuit of acquiring Guidant Corporation. The company revealed that it submitted a further revised definitive offer to Guidant on the same day. This revised offer was formally communicated via a letter from Boston Scientific's Chairman and CEO to Guidant's Chairman, indicating an ongoing and intensified effort to secure the acquisition. In conjunction with this revised offer, Boston Scientific also provided a signed merger agreement, signifying their readiness to proceed should Guidant accept the terms. This filing is crucial for investors as it highlights Boston Scientific's commitment and strategic moves in a high-stakes acquisition scenario, while also informing them about where to find additional disclosures and urging them to review forthcoming proxy statements for comprehensive details.
Key Highlights
- 1Boston Scientific submitted a further revised definitive offer to acquire Guidant Corporation.
- 2The revised offer was formally communicated on January 17, 2006.
- 3A signed merger agreement, prepared by Boston Scientific, was delivered to Guidant.
- 4This filing is categorized under 'Other Events' (Item 8.01).
- 5The press release announcing the revised offer and the merger agreement are attached as exhibits.
- 6Investors are urged to read future prospectus/proxy statements for important details regarding the proposed transaction.
- 7Boston Scientific is not currently soliciting proxies for this transaction.